Ignite Creation Date:
2024-05-06 @ 8:36 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02775006
Status:
TERMINATED
Last Update Posted:
2019-04-30
First Post:
2016-04-12
Brief Title:
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type ALK Negative Non Squamous Cell Carcinoma
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Organization Data
Organization:
The Netherlands Cancer Institute
Class:
OTHER
Study ID:
NVALT 18
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Netherlands Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Dutch Society of Physicians for Pulmonology and Tuberculosis | OTHER |